Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

Overview of attention for article published in Cancer Immunology, Immunotherapy, December 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs: 1 blog

patent: 4 patents

Citations

dimensions_citation: 469 Dimensions

Readers on

mendeley: 331 Mendeley

Summary Blogs Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Bispecific anti-CCL2 antibodies

Grant US-11739142-B2

United States of America

Methods for monitoring polymorphonuclear myeloid derived suppressor cells

Grant US-11073521-B2

United States of America

METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS' RESPONSE TO TREATMENT BY MEASURING…

Application WO-2016027273-A1

World Intellectual Property Organisation (WIPO)

PREDICTION OF RESPONSIVENESS TO TREATMENT WITH IMMUNOMODULATORY THERAPEUTICS AND METHOD…

Application EP-2817619-A4

European Patent Office